Pain is one of the most fundamental yet complex human biological experiences. A distinct category within this domain is orofacial pain. The orofacial region is anatomically complex, comprising a dense network of muscles, nerves and blood vessels. This complexity often makes the diagnosis and management of conditions affecting this area particularly challenging for clinicians. The primary aim of this study was to determine the global prevalence of oral and facial pain in the general population and to assess its distribution across different continents. Literature searches were conducted in the MEDLINE and Scopus databases. This analysis synthesized data from 155 observational studies published between 2004 and 2024, encompassing 1,712,161 participants and 163,154 reported cases. Statistical analyses were performed using the R statistical language. The pooled global prevalence of concurrent oral and facial pain was 19.19%. By continent, the prevalence rates were as follows: Africa - 27.44%; Asia - 30.78%; Australia - 15.58%; Europe - 12.27%; North America - 14.53%; and South America - 25.61%. Globally, the prevalence of concurrent oral and facial pain is 19%, compared with 12% for facial pain alone, and 21% for oral pain. Concurrent oral and facial pain was most common among individuals under 18 years of age (24%), decreasing to 16% among those aged 18-60 years and 10% in those aged >60 years. Females reported a higher prevalence (21%) of oral and facial pain than males (15%). Overall, the burden of concurrent oral and facial pain is greatest in Asia and South America, particularly among females, where prevalence exceeds 28%, while the lowest rates are found in Europe, especially among males (8%). The results of the present study should be interpreted with caution due to the high heterogeneity of the included studies. Further epidemiological research is recommended, employing rigorous methodology and adhering to current pain classification systems.
Orofacial pain, particularly when chronic and unrelated to dental pathology, presents a considerable diagnostic and therapeutic challenge. To address these issues, the International Classification of Orofacial Pain (ICOP), the first comprehensive international classification of orofacial pain, was published in 2020. The aim of this study was to determine the global prevalence of orofacial pain of different origin in accordance with the ICOP classification. A systematic search of MEDLINE and Scopus was conducted for observational studies published between 2004 and 2024. Although data were initially intended to be classified according to the ICOP categories, the available studies did not permit the direct application of this classification. The pooled prevalence estimates were as follows: myofascial orofacial pain - 20.60% (95% CI: 9.71-38.50; 5 studies, 3,395 observations); myofascial pain combined with temporomandibular joint (TMJ) pain - 11.95% (95% CI: 8.85-15.96; 31 studies, 522,056 observations); TMJ pain alone - 9.51% (95% CI: 6.01-14.73; 13 studies, 21,407 observations); orofacial pain attributed to dentoalveolar and related structures - 27.46% (95% CI: 22.83-32.63; 66 studies, 548,782 observations); and orofacial pain due to cranial nerve lesions or diseases - 7.98% (95% CI: 3.28-18.18; 2 studies, 9,735 observations). In the global population, the prevalence of myofascial orofacial pain is estimated at 21%. The prevalence of myofascial orofacial pain combined with TMJ pain is reported to be 12%. The prevalence of TMJ pain alone is estimated at 10%. The prevalence of orofacial pain attributed to the disorders of dentoalveolar and anatomically related structures is 27%. The prevalence of orofacial pain attributed to the lesions or diseases of the cranial nerves is 8%. The findings of this study should be interpreted with caution due to the substantial methodological heterogeneity observed across the included studies. This variability underscores the importance of establishing standardized criteria and reporting guidelines for orofacial pain in scientific research.